Authors
Loading...
Cross-sectional study reveals diagnostic routes impact biomarker testing and HRQOL in advanced colorectal cancer patients.
Yi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: